Penzkofer, Tobias http://orcid.org/0000-0001-9591-8575
Padhani, Anwar R.
Turkbey, Baris
Haider, Masoom A.
Huisman, Henkjan
Walz, Jochen
Salomon, Georg
Schoots, Ivo G.
Richenberg, Jonathan
Villeirs, Geert
Panebianco, Valeria
Rouviere, Olivier
Logager, Vibeke Berg
Barentsz, Jelle
Funding for this research was provided by:
Berlin Institute of Health (Clinician Scientist Program)
Article History
Received: 24 November 2020
Revised: 19 March 2021
Accepted: 27 April 2021
First Online: 15 May 2021
Declarations
:
: The scientific guarantor of this publication is Dr. Padhani.
: Dr. Penzkofer reports research agreements (no personal payments, outside of submitted work) with AGO, Aprea AB, ARCAGY-GINECO, Astellas Pharma Global Inc. (APGD), Astra Zeneca, Clovis Oncology, Inc., Dohme Corp, Holaira, Incyte Corporation, Karyopharm, Lion Biotechnologies, Inc., MedImmune, Merck Sharp, Millennium Pharmaceuticals, Inc., Morphotec Inc., NovoCure Ltd., PharmaMar S.A. and PharmaMar USA, Inc., Roche, Siemens Healthineers, and TESARO Inc.Dr. Padhani, Dr. Turkbey, Dr. Haider, Dr. Huisman, Dr. Walz, Dr. Salomon, Dr. Schoots, Dr. Richenberg, Dr. Villeirs, Dr. Panebianco, Dr. Rouviere, Dr. Berg Logager, and Dr. Barentsz declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was not required for this study because no human subjects were involved.
: Institutional Review Board approval was not required because no human subjects were involved.
: • Not applicable